Erratum

Author: Publishers

Source: Current Alzheimer Research, Volume 4, Number 2, April 2007 , pp. 231-231(1)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $63.10 plus tax (Refund Policy)

Abstract:

This is with reference to the article entitled, “Quetiapine to Treat Agitation in Dementia: A Randomized, Double-Blind, Placebo-Controlled Study”, by Kate X. Zhong, Pierre N. Tariot, Jacobo Mintzer, Margaret C. Minkwitz and Nancy A. Devine, published in Current Alzheimer Research, February 2007, Vol. 4, No. 1, pp. 81-93.

The authors unintentionally omitted to include the “Disclosure Information” in the article:

DISCLOSURE INFORMATION

Pierre N Tariot has received consulting fees and research support from Abbott Laboratories, Bristol-Myers Squibb, Janssen Pharmaceuticals and Eli Lilly & Company. He has also received consulting fees, research support and educational fees from AstraZeneca and Pfizer Inc and research support from the NIA, NIMH, Alzheimer's Association, Arizona Department of Health Services and the Institute for Mental Health Research.

Jacobo E Mintzer is a paid consultant and speaker for Abbott Laboratories Inc., AstraZeneca Pharmaceuticals Co., Ltd, Bristol-Myers Squibb, Johnson & Johnson and Pfizer Inc.

Document Type: Research article

DOI: http://dx.doi.org/10.2174/156720507780362128

Publication date: 2007-04-01

More about this publication?

Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Erratum

Buy & download fulltext article:

Tools

Key

Text size:

Useful pages